Genomtec S.A.
GMT.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| - Cash | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| + Debt | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Enterprise Value | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | 0% | -97.5% | -81.7% | – |
| Gross Profit | PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | 100% | -79,300% | -2,042.5% | -171.7% |
| EBITDA | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | -872,500% | -775,600% | -27,640% | -3,003.7% |
| Net Income | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | -1,120,800% | -901,300% | -29,820% | -3,248.9% |
| EPS Diluted | -0.84 | -0.74 | -1.27 | -0.87 |
| % Growth | -13.5% | 41.7% | -46% | – |
| Operating Cash Flow | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| Capital Expenditures | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| Free Cash Flow | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |